Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)

被引：0
|
作者：
Shirin, AD [1 ]
Volkova, MA [1 ]
机构：
[1] RUSSIAN ACAD MED SCI,CANC RES CTR,DEPT HEMATOL,MOSCOW,RUSSIA
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [31] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Iannella, E.
    Levi, A.
    Natalino, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2007, 31 : S107 - S107
  • [32] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [33] Cytogenetic changes in myelodysplastic syndromes (MDS)
    Haus, O
    Kotlarek-Haus, S
    Czarnecka, M
    Potoczek, S
    Kyrcz-Krzemien, S
    Duszenko, E
    Makowska, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
  • [34] Recent advances in myelodysplastic syndromes (MDS)
    Ascari, E
    HAEMATOLOGICA, 1998, 83 (03) : 287 - 288
  • [35] RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
    HAST, R
    CELSING, F
    EKMAN, M
    STENKE, L
    JOURNAL OF INTERNAL MEDICINE, 1991, 229 (04) : 381 - 382
  • [36] Adherence to treatment recommendations from a referral center for myelodysplastic syndromes (MDS)
    Kasprzak, A.
    Kondakci, M.
    Nachtkamp, K.
    Kobbe, G.
    Schroeder, T.
    Kuendgen, A.
    Kaivers, J.
    Rautenberg, C.
    Haas, R.
    Gattermann, N.
    Germing, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 44 - 44
  • [37] Oral idarubicin and GM-CSF for the treatment of myelodysplastic syndromes (MDS).
    Somasundram, U
    Hazel, D
    Newland, AC
    Hughes, A
    Boots, M
    Watts, E
    McMillan, AK
    Janmohammed, R
    Johnson, S
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 77 - 77
  • [38] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [39] Thalidomide alone or in combination with other agents for the treatment of myelodysplastic syndromes (MDS)
    Candoni, A.
    Raza, A.
    Galili, N.
    Simeone, E.
    Buttignol, S.
    Silvestri, F.
    Fanin, R.
    LEUKEMIA RESEARCH, 2007, 31 : S119 - S119
  • [40] Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group
    Kouraklis, A.
    Symeonidis, A.
    Galanopoulos, A.
    Kaiafa, G.
    Tavernarakis, I.
    Tsirakis, G.
    Michali, E.
    Tsaftaridis, P.
    Loukidis, K.
    Aggelidis, A.
    Zoumbos, N.
    LEUKEMIA RESEARCH, 2009, 33 : S119 - S120
12345